MedPath

Association of Bisphenol A,Paraben Exposure and Type 2 Diabetes

Not Applicable
Conditions
Bisphenol A
Type2 Diabetes
Interventions
Device: HPLC
Registration Number
NCT05177250
Lead Sponsor
Cairo University
Brief Summary

The aim of this study is to evaluate the association between BPA , paraben levels and type 2 DM patients

Detailed Description

The first phase of the study will include a questionnaire :

* The cases and control will be asked about demographic information such as residence, age, education, and occupation.

* History of discovery of diabetes.

* Exposure to products and materials such as polycarbonate plastics, cosmetics and beverages containing bisphenol A and paraben and it will be evaluated through exposure sheet through asking about dietary exposure, Environmental exposure and medical exposure.

Then clinical evaluation including:

* Full clinical examination will be performed for cases and control.

* Anthropological data:

their weights, heights and waist circumference will be measured. The body mass index (BMI) will be calculated by weight (kg)/height (m)2 formula.

* Investigations: routine and specific investigation as blood glucose level, HbA1c and lipid profile.

* Urine specimens will be collected in clean, glass containers will labeled with the subject identification number. Turbid sample or those containing blood will be excluded.

* All specimens will be stored frozen below 20 degree centigrade.

* Urine samples will be analyzed by High Performance liquid chromatograph (HPLC) to detect bispenol A and parabens levels.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Adult patients ( 18 y or elder).
  2. Type 2 DM
Exclusion Criteria
  • Type 1 DM
  • Less than 18 y
  • History of chronic diseases such as liver failure, cardiac patients......etc

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Case groupHPLC50 cases with type 2 DM.
Control groupHPLC50 subjects not diabetics.
Primary Outcome Measures
NameTimeMethod
Bisphenol A and paraben detection in urine samples of diabetic (n=50) and non diabetic persons (n=50)Baseline

Evaluation of bisphenol A and Paraben detection in urine samples from type 2 diabetic adult patients compared with non diabetic persons using HPLC

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ahmed Fathy

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath